Third time’s the charm? Agreement in principle reached on U.S.-EU data flows
By 
Aaron Nicodemus2022-03-25T17:14:00
The United States and European Union have reached an agreement in principle on how to handle transatlantic data flows, a thorny issue that has resulted in two prior frameworks being scrapped by the EU’s top court.
Related articles
-
ArticleU.S. includes surveillance concessions in new transatlantic data flow framework
President Joe Biden’s executive order on a data privacy framework aims to provide a workable, legally resilient solution for companies to continue moving and storing the personal data of EU-based citizens to American-based servers without running afoul of the GDPR.
-
ArticleFacebook fate in EU thrusts transatlantic data flows back in spotlight
Reports of a potential shutdown of Meta services Facebook and Instagram in the European Union that could take place as soon as this summer underscore what’s at stake as the region works with the United States to finalize a new agreement on how to handle transatlantic data flows.
-
ArticleExperts optimistic, though wary, toward Privacy Shield successor
Legal and data privacy experts have expressed cautious optimism regarding the announcement that the United States and European Union have reached an agreement in principle to resume transatlantic data flows.
More from Regulatory Policy
-
PremiumEU moves to simplify GDPR and AI Act obligations, raising compliance questions for companies
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
-
News BriefSEC exam priorities for 2026 signal heightened focus on firmwide compliance
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
-
ArticlePharma sector boom puts pressure on compliance to counter financial crime
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.